We are live on ! Find out more
SAMH

Shanda Asset Management Holdings Portfolio holdings

AUM $1.85B
1-Year Est. Return 36.09%
This Fund
S&P 500
This Quarter Est. Return
+27.64%
1 Year Est. Return
+36.09%
3 Year Est. Return
+114.94%
5 Year Est. Return
-33.67%
10 Year Est. Return
-25.97%
AUM
$1.11B
AUM Growth
+$675M
Cap. Flow
+$535M
Cap. Flow %
48.31%
Top 10 Hldgs %
47.89%
Holding
106
New
75
Increased
11
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$40.2M
2
AMZN icon
Amazon
AMZN
+$38.6M
3
TSM icon
TSMC
TSM
+$21.1M
4
BX icon
Blackstone
BX
+$21.1M
5
ZM icon
Zoom
ZM
+$16.2M

Top Sells

Rank Stock Value
1
W icon
Wayfair
W
+$42M
2
HTGC icon
Hercules Capital
HTGC
+$15M
3
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$10M
4
BA icon
Boeing
BA
+$6.18M
5
INTU icon
Intuit
INTU
+$4.6M

Sector Composition

Rank Sector Weight
1 Financials 19.49%
2 Communication Services 11.74%
3 Healthcare 11.41%
4 Technology 9.98%
5 Consumer Discretionary 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
76
KALA BIO
KALA
$14.5M
$491K 0.04%
+19
New +$538K
PRVB
77
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$485K 0.04%
+34,341
New +$434K
CLVS
78
DELISTED
Clovis Oncology, Inc.
CLVS
$479K 0.04%
+70,905
New +$537K
TVRD
79
Tvardi Therapeutics
TVRD
$23.4M
$474K 0.04%
+770
New +$425K
APRE icon
80
Aprea Therapeutics
APRE
$8.05M
$460K 0.04%
+593
New +$389K
ANAB icon
81
AnaptysBio
ANAB
$1.68B
$448K 0.04%
+20,039
New +$366K
OVID icon
82
Ovid Therapeutics
OVID
$491M
$377K 0.03%
+51,100
New +$239K
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$352K 0.03%
+68,970
New +$287K
VSTM icon
84
Verastem
VSTM
$610M
$298K 0.03%
+14,417
New +$381K
OYST
85
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$276K 0.02%
+9,559
New +$288K
ARDX icon
86
Ardelyx
ARDX
$997M
$263K 0.02%
+37,952
New +$264K
BCLI
87
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$258K 0.02%
+1,533
New +$165K
OBSV
88
DELISTED
ObsEva SA Ordinary Shares
OBSV
$239K 0.02%
+40,500
New +$153K
PLUR icon
89
Pluri
PLUR
$19.6M
$209K 0.02%
+2,950
New +$193K
NERV icon
90
Minerva Neurosciences
NERV
$199M
$147K 0.01%
+5,075
New +$298K
AVEO
91
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$147K 0.01%
+28,600
New +$181K
PHAS
92
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$140K 0.01%
+30,500
New +$135K
ALDX icon
93
Aldeyra Therapeutics
ALDX
$93.5M
$129K 0.01%
+31,000
New +$113K
IFRX icon
94
InflaRx
IFRX
$271M
$129K 0.01%
+28,000
New +$182K
TRAW icon
95
Traws Pharma
TRAW
$8.1M
$109K 0.01%
+512
New +$78.2K
NBRV
96
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$103K 0.01%
+608
New +$101K
MIST icon
97
Milestone Pharmaceuticals
MIST
$152M
$98K 0.01%
+26,000
New +$83.8K
AIM
98
AIM ImmunoTech
AIM
$7.91M
$72K 0.01%
+290
New +$70.4K
CRVO icon
99
CervoMed
CRVO
$26.6M
$59K 0.01%
+813
New +$49.5K
ARCC icon
100
Ares Capital
ARCC
$14.4B
– –
-103,030
Closed -$1.11M
1 2 3
4
5

Similar funds

DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return
CFA
Capstone Financial Advisors Downers Grove, Illinois $1.86B AUM 15.98% 1-Year Est. Return

Shanda Asset Management Holdings's Q2 2020 Portfolio in Review

As of Q2 2020, Shanda Asset Management Holdings held 106 positions worth $1.11B, up 156% from $433M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Shanda Asset Management Holdings deployed $535M of net new capital in Q2 2020, opening 75 new positions and adding to 11 existing holdings. Its largest new stake was TSMC: 400,000 shares worth $22.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 23% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Wayfair, an estimated $42M trimmed.

  • Shanda Asset Management Holdings's largest Q2 2020 buy was TSMC: 400,000 shares worth $22.7M.
  • Shanda Asset Management Holdings added most to Visa in Q2 2020, an estimated $40.2M increase.
  • Shanda Asset Management Holdings's biggest Q2 2020 reduction was Wayfair, cutting an estimated $42M.
  • Shanda Asset Management Holdings fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2020, selling an estimated $10M.
  • Shanda Asset Management Holdings's ten largest holdings make up 48% of its $1.11B portfolio in Q2 2020.
  • Shanda Asset Management Holdings opened 75 new positions and closed 7 in Q2 2020.
  • Shanda Asset Management Holdings's portfolio value rose 156% quarter-over-quarter to $1.11B.

Based on Shanda Asset Management Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.